Babylon Set to Join Russell 3000® Index
Babylon (NYSE:BBLN) will be added to the Russell 3000® Index effective June 27, 2022, following the annual reconstitution. This inclusion reflects the company's strong market capitalization and positions it among the top 4,000 US stocks, reinforcing its growth trajectory within a year of its NYSE listing. CEO Ali Parsa emphasized that this milestone will enhance Babylon's visibility to institutional investors, aligning with their mission to provide accessible healthcare globally.
- Inclusion in the Russell 3000® Index enhances visibility to institutional investors.
- Reflects strong market capitalization within one year of NYSE listing.
- None.
Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of
"We are delighted to have been selected to join the Russell 3000® Index within a year of our listing on the NYSE, showing that you can do good and do well,” said
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately
For more information on the Russell 3000® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.
About Babylon
Babylon is one of the world’s fastest growing digital healthcare companies whose mission is to make high-quality healthcare accessible and affordable for every person on Earth.
Babylon is re-engineering how people engage with their care at every step of the healthcare continuum. By flipping the model from reactive sick care to proactive healthcare through the devices people already own, it offers millions of people globally ongoing, always-on care. Babylon has already shown that in environments as diverse as the developed
Founded in 2013, Babylon’s technology and clinical services is supporting a global patient network across 15 countries, and is capable of operating in 16 languages. And through a combination of its value-based care model, Babylon 360, and its work in primary care through NHS GP at Hand, Babylon managed over 440k lives globally from the start of 2022. In 2021 alone, Babylon helped a patient every 6 seconds, with approximately 5.2 million consultations and AI interactions. Importantly, this was achieved with a
Babylon is also working with governments, health providers, employers and insurers across the globe to provide them with a new infrastructure that any partner can use to deliver high-quality healthcare with lower costs and better outcomes. For more information, please visit www.babylonhealth.com.
About FTSE Russell
FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering
FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately
A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering.
FTSE Russell is wholly owned by London Stock Exchange Group.
For more information, visit www.ftserussell.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220609005384/en/
Media
press@babylonhealth.com
Investors
investors@babylonhealth.com
Source: Babylon
FAQ
When does Babylon join the Russell 3000® Index?
What does being added to the Russell 3000® Index mean for Babylon (BBLN)?
What is the significance of the Russell 3000® Index for investors?